You are here:Home-Chemical Inhibitors & Agonists-Ras-Raf-MAPK-ERK Pathway-JNK-CC-401 hydrochloride
CC-401 hydrochloride

Chemical Structure : CC-401 hydrochloride

CAS No.: 1438391-30-0

CC-401 hydrochloride (CC 401 hydrochloride;CC401 hydrochloride;CC401 HCl)

Catalog No.: PC-43332Not For Human Use, Lab Use Only.

CC-401 hydrochloride is a potent, selective, ATP-competitive pan-JNK inhibitor with Ki of 25-50 nM, displays >40-fold selectivity over other related kinases, including p38, ERK, IKK2, PK C, Lck, and ZAP70.

Packing Price Stock Quantity
10 mg $158 In stock
25 mg $258 In stock
50 mg $378 In stock
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

CC-401 hydrochloride is a potent, selective, ATP-competitive pan-JNK inhibitor with Ki of 25-50 nM, displays >40-fold selectivity over other related kinases, including p38, ERK, IKK2, PK C, Lck, and ZAP70.
CC-401 decreases hepatic necrosis and apoptosis after orthotopic liver transplantation in vivo.
CC-401 blocks JNK signaling in the rat obstructed kidney and significantly inhibits renal fibrosis in terms of interstitial myofibroblast accumulation and collagen IV deposition.
CC-401 also significantly reduces tubular apoptosis in the obstructed kidney.
CC-401 sensitizes hypoxic colon cancer cells to DNA-damaging agents, potentiates the effect of bevacizumab and oxaliplatin in HT29-derived mouse xenografts.

Physicochemical Properties

M.Wt 424.9265
Formula C22H25ClN6O
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

100 mM in DMSO (42.4 mg/mL)

Chemical Name/SMILES

1H-Indazole, 3-[3-[2-(1-piperidinyl)ethoxy]phenyl]-5-(1H-1,2,4-triazol-5-yl)-, hydrochloride (1:1)

References

1. Uehara T, et al. Transplantation. 2004 Aug 15;78(3):324-32.

2. Uehara T, et al. J Hepatol. 2005 Jun;42(6):850-9.

3. Ma FY, et al. J Am Soc Nephrol. 2007 Feb;18(2):472-84.

4. Vasilevskaya IA, et al. Clin Cancer Res. 2015 Sep 15;21(18):4143-52.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: